Data Tables


Sections I - VIII
I. Summary Tables
II. Deceased and Living Donor Characteristics
III. Deceased Donor Organ Recovery and Disposition
IV. Organ Procurement Organization Tables
V. Kidney Tables
VI. Pancreas Transplant Alone (PTA) Tables
VII. Pancreas After Kidney (PAk) Tables
VIII. Kidney-Pancreas Tables
Sections IX - XV
IX. Liver Tables
X. Intestine Tables
XI. Heart Tables
XII. Lung Tables
XIII. Heart-Lung Tables
XIV. Donor and Recipient Tumor Tables
XV. Supplementary Tables
  Technical Notes and Analytic Methods
  All Data Tables (214 K)

View HTML View PDF

Section XI
11.1aWaiting List Patient Characteristics at End of Year Heart Waiting List Active Waitlist Patients, 1995 to 2004Table 11.1a (43 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Patient Status
Previous Transplant Same Organ
Time on Waiting List
11.1bWaiting List Patient Characteristics at End of Year Heart Waiting List Active and Inactive Patient Comparison, 2000 to 2004Table 11.1b (37 k)
Age
Diagnosis
Gender
Race
Time on Waiting List
11.2aEvents 7 & 30 Days After Listing 2003 and 2004 Heart Registrations with Initial Status 1ATable 11.2a (20 k)
11.2bEvents 30 Days After Snapshot of Prevalent Waiting List Patients on Heart Waiting List on Jan. 1, 2004Table 11.2b (34 k)
30 Days After Snapshot
60 Days After Snapshot
90 Days After Snapshot
11.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2004 Heart Waiting ListTable 11.3 (45 k)
Age
Blood Type
Gender
Patient Status
Race
11.4Transplant Recipient Characteristics, 1995 to 2004 Heart RecipientsTable 11.4 (47 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Diagnosis
Cold Ischemia Time
On Life Support at TX
Hospitalized at Transplant
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
11.5Incidence of Transplant, 1995 to 2004 Heart Transplants per 1 Million PopulationTable 11.5 (29 k)
11.6aImmunosuppression Use for Induction, 1995 to 2004 Recipients with Heart TransplantsTable 11.6a (30 k)
11.6bImmunosuppression Use for Induction by Discharge Regimen, 2000 to 2004 Recipients with Heart TransplantsTable 11.6b (32 k)
11.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2000 to 2004 Recipients with Heart TransplantsTable 11.6c (29 k)
11.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1995 to 2004 Recipients with Heart TransplantsTable 11.6d (30 k)
11.6eImmunosuppression Use for Maintenance Prior to Discharge, 1995 to 2004 Recipients with Heart TransplantsTable 11.6e (32 k)
11.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1994 to 2003 Recipients with Heart TransplantsTable 11.6f (32 k)
11.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1994 to 2003 Recipients with Heart TransplantsTable 11.6g (32 k)
11.6hPersistency of Discharge Regimen by Follow-up Period, 1999 to 2003 Recipients with Heart TransplantsTable 11.6h (34 k)
11.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1994 to 2003 Recipients with Heart TransplantsTable 11.6i (31 k)
11.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2003 Rates for Recipients during First Year after Heart TransplantationTable 11.7 (71 k)
Blood Type
Residency
Gender
Patient Status
Race
Age of Donor
Procedure Type
Age
Cold Ischemia Time
On Life Support at TX
Hospitalized at Transplant
Previous Transplant Any Organ
Diagnosis
11.8Adjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 11.8 (36 k)
Age
Gender
Race
Diagnosis
11.9Unadjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 11.9 (46 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Age of Donor
Previous Transplant Same Organ
Procedure Type
Diagnosis
Cold Ischemia Time
On Life Support at TX
Hospitalized at Transplant
11.10Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Heart TransplantsTable 11.10 (29 k)
11.11Adjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 11.11 (36 k)
Age
Gender
Race
Diagnosis
11.12Unadjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 11.12 (46 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Age of Donor
Procedure Type
Diagnosis
Cold Ischemia Time
On Life Support at TX
Hospitalized at Transplant
11.13Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Heart TransplantsTable 11.13 (29 k)
11.14Prevalence of People Living with a Functioning Transplant at End of Year Heart Recipients, 1995 to 2004Table 11.14 (44 k)
Blood Type
Residency
Gender
Patient Status
Race
Age
Diagnosis
On Life Support at TX
Hospitalized at Transplant
Previous Transplant Same Organ
Previous Transplant Any Organ
Procedure Type
11.15Transplants by State and Transplant Center, 1995 to 2004 HeartTable 11.15 (72 k)